I
Intellia Therapeutics, Inc. (NTLA)
12.37
0.00 (0.00%)

12.37
0.00 (0.00%)
This stock has a consensus price target of $26.23 based on the ratings of 29 analysts. The high is $65.00 and the low is $5.00.
| Цель | Мин. целевая цена | Средн. целевая цена | Макс. целевая цена |
|---|---|---|---|
| Цена | $ 5 | $ 26.23 | $ 65 |
| Изменение | -59.58% | 112.05% | 425.46% |
| Дата | Потенциал роста/падения | Аналитическая компания | Целевая цена | Изменение рейтинга | Рейтинг |
|---|---|---|---|---|---|
| 2026-03-04 | 134.44% | Jones Trading | $29 | Upgrades | Hold → Buy |
| 2026-03-03 | 288.04% | Canaccord Genuity | $54 → $48 | Maintains | Buy |
| 2026-03-03 | 134.44% | Leerink Partners | $27 → $29 | Maintains | Outperform |
| 2026-03-03 | 21.26% | RBC Capital | $9 → $15 | Maintains | Sector Perform |
| 2026-03-03 | 21.26% | Wells Fargo | $12 → $15 | Maintains | Equal-Weight |